These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35687212)
1. Fluorescent A Toti KS; Campbell RG; Lee H; Salmaso V; Suresh RR; Gao ZG; Jacobson KA Purinergic Signal; 2023 Sep; 19(3):565-578. PubMed ID: 35687212 [TBL] [Abstract][Full Text] [Related]
2. Allosteric Antagonism of the A Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA Cells; 2020 May; 9(5):. PubMed ID: 32408534 [TBL] [Abstract][Full Text] [Related]
3. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A Comeo E; Kindon ND; Soave M; Stoddart LA; Kilpatrick LE; Scammells PJ; Hill SJ; Kellam B J Med Chem; 2020 Mar; 63(5):2656-2672. PubMed ID: 31887252 [TBL] [Abstract][Full Text] [Related]
4. Bitopic fluorescent antagonists of the A Duroux R; Ciancetta A; Mannes P; Yu J; Boyapati S; Gizewski E; Yous S; Ciruela F; Auchampach JA; Gao ZG; Jacobson KA Medchemcomm; 2017 Aug; 8(8):1659-1667. PubMed ID: 29250307 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of DPTN and other selective A Gao ZG; Suresh RR; Jacobson KA Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378 [TBL] [Abstract][Full Text] [Related]
6. Exploring the Role of N Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789 [TBL] [Abstract][Full Text] [Related]
7. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists. Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666 [TBL] [Abstract][Full Text] [Related]
8. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976 [TBL] [Abstract][Full Text] [Related]
9. A Spinaci A; Lambertucci C; Buccioni M; Dal Ben D; Graiff C; Barbalace MC; Hrelia S; Angeloni C; Tayebati SK; Ubaldi M; Masi A; Klotz KN; Volpini R; Marucci G Molecules; 2022 Apr; 27(8):. PubMed ID: 35458588 [TBL] [Abstract][Full Text] [Related]
10. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors. Tian Y; Marshall M; French BA; Linden J; Yang Z Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314 [TBL] [Abstract][Full Text] [Related]
11. Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor. Kozma E; Gizewski ET; Tosh DK; Squarcialupi L; Auchampach JA; Jacobson KA Biochem Pharmacol; 2013 Apr; 85(8):1171-81. PubMed ID: 23376019 [TBL] [Abstract][Full Text] [Related]
12. High ligand efficiency quinazoline compounds as novel A Bolteau R; Duroux R; Laversin A; Vreulz B; Shiriaeva A; Stauch B; Han GW; Cherezov V; Renault N; Barczyk A; Ravez S; Coevoet M; Melnyk P; Liberelle M; Yous S Eur J Med Chem; 2022 Nov; 241():114620. PubMed ID: 35933788 [TBL] [Abstract][Full Text] [Related]
13. Identification of V6.51L as a selectivity hotspot in stereoselective A Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993 [TBL] [Abstract][Full Text] [Related]
15. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists. Al-Salahi R; Geffken D; Koellner M Chem Pharm Bull (Tokyo); 2011; 59(6):730-3. PubMed ID: 21628909 [TBL] [Abstract][Full Text] [Related]
16. [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A Federico S; Persico M; Trevisan L; Biasinutto C; Bolcato G; Salmaso V; Da Ros T; Gianferrara T; Prencipe F; Kachler S; Klotz KN; Pacor S; Moro S; Spalluto G ChemMedChem; 2023 Nov; 18(21):e202300299. PubMed ID: 37675643 [TBL] [Abstract][Full Text] [Related]
17. Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. Vincenzi F; Targa M; Corciulo C; Gessi S; Merighi S; Setti S; Cadossi R; Goldring MB; Borea PA; Varani K PLoS One; 2013; 8(5):e65561. PubMed ID: 23741498 [TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Benzo[4,5]imidazo[1,2- Liu S; Ding W; Huang W; Zhang Z; Guo Y; Zhang Q; Wu L; Li Y; Qin R; Li J; Shi T; Zhang X; Lei J; Hu W J Med Chem; 2022 Jul; 65(13):8933-8947. PubMed ID: 35714367 [TBL] [Abstract][Full Text] [Related]
19. Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles. Jayasekara PS; Phan K; Tosh DK; Kumar TS; Moss SM; Zhang G; Barchi JJ; Gao ZG; Jacobson KA Purinergic Signal; 2013 Jun; 9(2):183-98. PubMed ID: 23179047 [TBL] [Abstract][Full Text] [Related]